Literature DB >> 2351167

The metabolism of 15-p-[123I]-iodophenylpentadecanoic acid in a surgically induced canine model of regional ischemia.

M P Hudon1, D M Lyster, W R Jamieson, A K Qayumi, C Sartori, H Dougan.   

Abstract

The purpose of this study was to examine the longitudinal effect of gradual coronary occlusion on regional myocardial metabolism of 15-p-123I-iodophenylpentadecanoic acid [( 123I]IPPA). Adult dogs were imaged using [123I]IPPA and planar gamma imaging. A thoracotomy was performed and an ameroid constrictor of appropriate size permanently positioned on the left anterior descending coronary artery. The dogs were imaged after injection of 3-5 mCi [123I]IPPA at various times over a 2-week period. With imaging on days 7 and 14, the dogs were paced at a rate of 185. Time-activity curves were generated and t1/2 values calculated using monoexponential curve fitting. Results indicate a significant increase in t1/2 between control and 14 days after surgery in the apical wall (29 +/- 7 to 53 +/- 18 min; P less than 0.05). Although there was also an increased t1/2 in the lateral wall, this was not significant (27 +/- 8 to 78 +/- 99 min; P greater than 0.05). There was no significant change in t1/2 in the septal wall (27 +/- 9 to 33 +/- 8 min; P greater than 0.05). We conclude that [123I]IPPA is a useful indicator of developing myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351167     DOI: 10.1007/bf00842769

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  21 in total

1.  Noncoronary collateral myocardial blood flow.

Authors:  J Brazier; C Hottenrott; G Buckberg
Journal:  Ann Thorac Surg       Date:  1975-04       Impact factor: 4.330

2.  Pressure studies after inactivation of the major portion of the canine right ventricle.

Authors:  D E Donald; H E Essex
Journal:  Am J Physiol       Date:  1954-01

3.  Assessment of myocardial metabolism by PET--a sophisticated dream or clinical reality?

Authors:  H R Schelbert
Journal:  Eur J Nucl Med       Date:  1986

4.  Myocardial uptake of radioactively labelled free fatty acids.

Authors:  G Westera; F C Visser
Journal:  Eur Heart J       Date:  1985-08       Impact factor: 29.983

5.  Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium.

Authors:  D D Miller; J B Gill; E Livni; D R Elmaleh; T Aretz; C A Boucher; H W Strauss
Journal:  Circ Res       Date:  1988-10       Impact factor: 17.367

6.  Myocardial scintigraphy with 123I-labelled heptadecanoic acid in patients with unstable angina pectoris.

Authors:  E E van der Wall; G A Heidendal; W den Hollander; G Westera; J P Roos
Journal:  Postgrad Med J       Date:  1983       Impact factor: 2.401

7.  Regional myocardial free fatty acid extraction in normal and ischemic myocardium.

Authors:  K Vyska; H J Machulla; W Stremmel; D Fassbender; W H Knapp; G Notohamiprodjo; U Gleichmann; H Meyer; E J Knust; R Körfer
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

8.  Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardium.

Authors:  H J Machulla; M Marsmann; K Dutschka
Journal:  Eur J Nucl Med       Date:  1980-04

9.  Metabolism of 15 (p 123I iodophenyl-)pentadecanoic acid in heart muscle and noncardiac tissues.

Authors:  S N Reske; W Sauer; H J Machulla; J Knust; C Winkler
Journal:  Eur J Nucl Med       Date:  1985

10.  Effect of myocardial perfusion and metabolic interventions on cardiac kinetics of phenylpentadecanoic acid (IPPA) I 123.

Authors:  S N Reske; S Schön; W Schmitt; H J Machulla; R Knopp; C Winkler
Journal:  Eur J Nucl Med       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.